US$ 23.06
glp 1 receptor agonist heart failure Effects of Glucagon-Like Peptide Initiation in Patients With With Reduced Ejection Fraction and Implantable Cardiac Devices Impact of GLP-1 receptor agonists
Description
Asia Pacific is emerging as the fastest-growing region, driven by rising rates of type 2 diabetes, urban obesity, and expanding healthcare access

How GLP-1 Drugs Promote Weight Loss Signals a feeling of being full Slows down digestion Regulates the release of insulin from the pancreas Who Is Eligible to Use GLP-1 Drugs for Weight Loss

Potential mechanisms Mol Metab
Blasco BV, Garca-Jimnez J, Bodoano I, Gutirrez-Rojas L

Holst, David A
